CA, P., RG, S., JA, C., DP, A., S, P., RJ, B., . . . BS, R. (2008). TGFB1 single nucleotide polymorphisms are associated with adverse quality of life in prostate cancer patients treated with radiotherapy. International journal of radiation oncology, biology, physics, 70(3), 752. https://doi.org/10.1016/j.ijrobp.2007.05.023
Chicago Style (17th ed.) CitationCA, Peters, Stock RG, Cesaretti JA, Atencio DP, Peters S, Burri RJ, Stone NN, Ostrer H, and Rosenstein BS. "TGFB1 Single Nucleotide Polymorphisms Are Associated with Adverse Quality of Life in Prostate Cancer Patients Treated with Radiotherapy." International Journal of Radiation Oncology, Biology, Physics 70, no. 3 (2008): 752. https://doi.org/10.1016/j.ijrobp.2007.05.023.
MLA (9th ed.) CitationCA, Peters, et al. "TGFB1 Single Nucleotide Polymorphisms Are Associated with Adverse Quality of Life in Prostate Cancer Patients Treated with Radiotherapy." International Journal of Radiation Oncology, Biology, Physics, vol. 70, no. 3, 2008, p. 752, https://doi.org/10.1016/j.ijrobp.2007.05.023.